ArticleJournal of traumatic stress2023
Minimal important difference metrics and test-retest reliability of the PTSD Checklist for DSM-5 with a primary care sample.
Article in Journal of traumatic stress, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 30 citations in OpenAlex.
- Skills Training in Affective Recovery Video and Text Programs for Recent Sexual Assault Survivors: A Pilot Randomized Clinical Trial.JAMA network open · 2026Trial
- Adaptive, Stepped-Care for Cancer-Related PTSD Symptoms in HCT Survivors: Results From a SMART Trial.Psycho-oncology · 2026Trial
- Group Therapy for Posttraumatic Stress Disorder Symptoms Among Veterans With Military Sexual Trauma: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Testing a Smartphone-Based Intervention Targeting Anxiety Sensitivity Among Women Presenting for Emergency Care After Sexual Assault: Pilot Randomized Controlled Trial.JMIR formative research · 2026Trial
- Examining why therapists add sessions to the written exposure therapy protocol and whether it improves treatment outcome: A mixed-methods analysis.Psychological services · 2026Trial
- Enhanced Weight Management Program for Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Racial Differences in Trauma Outcomes After a Mindfulness App Intervention in Frontline Nurses: A Secondary Data Analysis.Issues in mental health nursing · 2025Trial
- Associations among sleep quality, cognitive processing therapy, and posttraumatic stress disorder symptoms in a primary care setting.Journal of traumatic stress · 2025Trial
- Prolonged exposure in routine outpatient care: a naturalistic study of feasibility, safety and effectiveness.European journal of psychotraumatology · 2026Article
- A Clinician-Supported Mobile App to Reduce Mental Health Symptoms Among World Trade Center Responders in Florida: Protocol for a Randomized Controlled Trial.JMIR research protocols · 2026Article
- The Richards Trauma Process: a before-after single-arm feasibility trial of a novel psychotherapy.Pilot and feasibility studies · 2026Article
- Symptom benchmarks of improved quality of life among military veterans with PTSD.Journal of mood and anxiety disorders · 2026Article
- Experienced and Anticipated Intersectional Violence and Psychological Distress Symptom Severity Among Black Transgender Women in the United States of America.Healthcare (Basel, Switzerland) · 2026Article
- Pretraining neural and neuropsychological measures of executive functioning are associated with response to working memory training in Veterans with PTSD.Psychological medicine · 2026Article
- Complementary and integrative health interventions for PTSD in Veterans and family members: A rapid systematic review and meta-analysis.Journal of military, veteran and family health · 2026Article
- Horsepower: equine-assisted interventions are associated with reduced PTSD symptoms, improved sleep quality, and quality of life in military veterans with treatment-resistant PTSD.Frontiers in psychology · 2026Article
- Feasibility and acceptability of written exposure therapy group in a virtual outpatient setting.Journal of traumatic stress · 2025Article
- The Therapeutic Effect of High-definition 1-Hz Transcranial Alternating Current Stimulation in PTSD: A Randomized Controlled Trial.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025Article
- Reliable symptom worsening among veterans receiving cognitive processing therapy or prolonged exposure therapy for posttraumatic stress disorder in routine Veterans Health Administration care.Journal of affective disorders · 2025Article
- Posttraumatic stress disorder in the preconception period: an open pilot feasibility study.Maternal health, neonatology and perinatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
Abstract
The PTSD Checklist for DSM-5 (PCL-5) is a measure of posttraumatic stress disorder (PTSD) symptom severity that is widely used for clinical and research purposes. Although previous work has examined metrics of minimal important difference (MID) of the PCL-5 in veteran samples, no work has identified PCL-5 MID metrics among adults in primary care in the United States. In this secondary analysis, data were evaluated from primary care patients (N = 971) who screened positive for PTSD and participated in a large clinical trial in federally qualified health centers in three U.S. states. Participants primarily self-identified as women (70.2%) and White (70.3%). We calculated test-retest reliability using clinic registry data and multiple distribution- and anchor-based metrics of MID using baseline and follow-up survey data. Test-retest reliability (Pearson's r, Spearman's ρ, intraclass correlation coefficient) ranged from adequate to excellent (.79-.94), with the shortest time lag demonstrating the highest reliability estimate. The MID for the PCL-5 was estimated using multiple approaches. Distribution-based approaches indicated an MID range of 8.5-12.5, and anchor-based approaches indicated an MID range of 9.8-11.7. Taken together, the MID metrics indicate that PCL-5 change scores of 9-12 likely reflect real change in PTSD symptoms and indicate at least an MID for patients, whereas PCL-5 change scores of 5 or less likely are not reliable. These findings can help inform clinicians using the PCL-5 in similar populations to track patient responses to treatment and help researchers interpret PCL-5 score changes in clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.